<SEC-DOCUMENT>0001214659-24-006045.txt : 20240404
<SEC-HEADER>0001214659-24-006045.hdr.sgml : 20240404
<ACCEPTANCE-DATETIME>20240403173818
ACCESSION NUMBER:		0001214659-24-006045
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240404
DATE AS OF CHANGE:		20240403
EFFECTIVENESS DATE:		20240404

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ELI LILLY & Co
		CENTRAL INDEX KEY:			0000059478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				350470950
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-06351
		FILM NUMBER:		24820383

	BUSINESS ADDRESS:	
		STREET 1:		LILLY CORPORATE CTR
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285
		BUSINESS PHONE:		3172762000

	MAIL ADDRESS:	
		STREET 1:		LILLY CORPORATE CENTER
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LILLY ELI & CO
		DATE OF NAME CHANGE:	19941024

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mercy Investment Services, Inc.
		CENTRAL INDEX KEY:			0001699865
		ORGANIZATION NAME:           	
		IRS NUMBER:				263224636
		STATE OF INCORPORATION:			MO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		2039 NORTH GEYER ROAD
		CITY:			ST. LOUIS
		STATE:			MO
		ZIP:			63131
		BUSINESS PHONE:		314-909-4609

	MAIL ADDRESS:	
		STREET 1:		2039 NORTH GEYER ROAD
		CITY:			ST. LOUIS
		STATE:			MO
		ZIP:			63131
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>b43242px14a6g.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Notice of Exempt Solicitation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NAME OF REGISTRANT:&nbsp;</B>Eli Lilly and Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NAME OF PERSON RELYING ON EXEMPTION:&nbsp;</B>CommonSpirit Health</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ADDRESS OF PERSON RELYING ON EXEMPTION:</B>
2039 N. Geyer Rd., St. Louis, MO 63131</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Eli Lilly and Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Vote FOR: Item #9 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annual Meeting: May 6, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Contact: Laura Krausa &bull; CommonSpirit Health</B>
&bull; <B>laura.krausa@commonspirit.org</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="padding-top: 2pt; text-align: center; font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; background-color: #EEECE1; padding-bottom: 2pt"><B>Introduction</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 3, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To Fellow Eli Lilly Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CommonSpirit Health, along with co-filers Grand Rapids Dominicans;
Sisters of St. Joseph of Peace, WA; Bon Secours Mercy Health; Daughters of Charity, Province of St. Louis; and Providence St. Joseph Health
(together, the &ldquo;Proponents&rdquo;), are <B>urging stockholders to vote FOR Item #9</B>, (the Proposal&rdquo;),
at the Eli Lilly and Company (&ldquo;Lilly&rdquo; or the &ldquo;Company&rdquo;) stockholder meeting on May 6, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Proposal calls on Lilly&rsquo;s board to adopt a comprehensive
human rights policy, referencing internationally recognized human rights standards, that applies to both its own operations and its suppliers
that includes the right to health and establishes a process to identify, prevent, mitigate, and remedy adverse human rights impacts, above
and beyond supplier audits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; padding-top: 2pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: #EEECE1; padding-bottom: 2pt"><B>Rationale for a FOR Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>We believe the Proposal would:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Codify Lilly&rsquo;s commitment to the right to health and access to medicine</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Ground Lilly&rsquo;s access to medicine initiatives in the human rights principles of equality and non-discrimination, transparency,
participation, and accountability</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Establish a human rights due diligence process by which Lilly can identify, prevent, mitigate, and remedy adverse human rights impacts
it causes or to which it contributes</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; padding-top: 2pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: #EEECE1; padding-bottom: 2pt"><B>Discussion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The right to health is enshrined in international
human rights principles:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>The Universal Declaration of Human Rights (&ldquo;UDHR&rdquo;) states, &ldquo;Everyone has the right to a standard of living adequate
for the health and well-being of himself and of his family, including . . . medical care.&rdquo;<SUP>1</SUP></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Article 12.1 of the International Covenant on Economic, Social, and Cultural Rights (&ldquo;ICESCR&rdquo;) &ldquo;recognize[s] the
right of everyone to the enjoyment of the highest attainable standard of physical and mental health.&rdquo;<SUP>2</SUP></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>The World Health Organization&rsquo;s Constitution states, &ldquo;The enjoyment of the highest attainable standard of health is one
of the fundamental rights of every human being without distinction of race, religion, political belief, economic or social condition.&rdquo;<SUP>3</SUP></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">According to the U.N. Special Rapporteur on
the right to health (the &ldquo;Special Rapporteur&rdquo;), &ldquo;[t]he issue of access to medicines is a fundamental component of the
full realization of the right to health. Medical care in the event of sickness and the prevention, and treatment and control of diseases,
depends largely on timely and appropriate access to quality medicines. . . . From a human rights perspective, access to medicines is intrinsically
linked with the principles of equality and non-discrimination, transparency, participation, and accountability.&rdquo;<SUP>4</SUP>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Pharmaceutical companies &ldquo;ha[ve] an
indispensable role to play in relation to the&nbsp;right to health&nbsp;and access to medicines,&rdquo; but their policies have been cited
as a barrier to access.<SUP>5</SUP> The Special
Rapporteur&rsquo;s &ldquo;Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines&rdquo; (the &ldquo;Guidelines&rdquo;)
recommend that pharmaceutical firms &ldquo;should adopt a human rights policy statement which expressly recognises the importance of human
rights generally, and the right to the highest attainable standard of health in particular&rdquo; and &ldquo;should integrate human rights,
including the right to the highest attainable standard of health, into the strategies, policies, programmes, projects and activities of
the company.&rdquo; <SUP>6</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Specifically, the Guidelines urge that pharmaceutical
companies should &ldquo;be as transparent as possible&rdquo; with regard to access to medicines; &ldquo;disclose all current advocacy
and lobbying positions, and related activities, at the regional, national and international levels, that impact or may impact upon access
to medicines&rdquo;; and &ldquo;consider all the arrangements at its disposal with a view to ensuring that its medicines are affordable
to as many people as possible.&rdquo;<SUP>7</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">In 2022, the General Assembly of the World
Health Organization established the goal that &ldquo;100% of people with type 1 diabetes have access to affordable insulin and blood glucose
self-monitoring&rdquo; by 2030.<SUP>8</SUP>
<SUP>9</SUP></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.ohchr.org/en/human-rights/universal-declaration/translations/english
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.ohchr.org/en/instruments-mechanisms/instruments/international-covenant-economic-social-and-cultural-rights;
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605313 </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.who.int/about/accountability/governance/constitution</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>4</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.ohchr.org/en/special-procedures/sr-health/access-medicines-and-right-health</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>5</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">SYMPOSIUM ARTICLE: Human Rights Responsibilities
of Pharmaceutical Companies in Relation to Access to Medicines, 40 J.L. Med. &amp; Ethics 220</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Summer
2012)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>6</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.ohchr.org/Documents/Issues/Health/GuidelinesForPharmaceuticalCompanies.doc,
paras 1-2 </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>7</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guidelines, paras. 6, 17, 33</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>8</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.who.int/news-room/feature-stories/detail/first-ever-global-coverage-targets-for-diabetes-adopted-at-the-75-th-world-health-assembly</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>9</SUP><FONT STYLE="background-color: white">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141427/</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This communication is not a solicitation of proxy
authority and no proxy cards will be accepted. Vote your proxies in accordance with Eli Lilly&rsquo;s instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">We believe that viewing the right to health
and access to medicine through a human rights lens would help strengthen Lilly&rsquo;s access commitments and bring Lilly&rsquo;s record
on access in line with peers. Lilly ranked last of the 20 global pharmaceutical firms assessed in the 2022 Access to Medicine Index, the
most recent available.<SUP>10</SUP> The Access to Medicine
Index &ldquo;evaluates and compares 20 of the world&rsquo;s leading research-based pharmaceutical companies according to their efforts
to improve access to medicine in [low- and middle-income countries],&rdquo;<SUP>11</SUP>
which is consistent with Lilly&rsquo;s focus on &ldquo;people living in communities with limited resources,&rdquo; as described in the
Statement in Opposition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">On specific rating components, Lilly had the
lowest score on &ldquo;Product Delivery&rdquo; and the second-lowest score on &ldquo;Governance of Access&rdquo;; its &ldquo;Research
&amp; Development&rdquo; score fell in the bottom five.<SUP>12</SUP>
The 2022 Access to Medicine Index report faulted Lilly for lack of transparency--&ldquo;The company chooses not to disclose information
across a range of issues, nor to make relevant information available in the public domain&rdquo;<SUP>13</SUP>&mdash;and
for its lack of a &ldquo;systematic framework&rdquo; for access planning for all new products, which three-quarters of the ranked companies
had.<SUP>14</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Human rights due diligence is necessary to implement a commitment to
respect the right to health. The United Nations Guiding Principles on Business and Human Rights provide that businesses need three elements
to meet their responsibility to respect human rights: a policy commitment to respect human rights; a &ldquo;human rights due diligence
process to identify, prevent, mitigate and account for how they address their impacts on human rights&rdquo;; and a process for remedying
adverse human rights impacts.<SUP>15</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Identifying potential impacts involves &ldquo;assessing the human rights
context prior to a proposed business activity, where possible; identifying who may be affected; cataloguing the relevant human rights
standards and issues; and projecting how the proposed activity and associated business relationships could have adverse human rights impacts
on those identified.&rdquo;<SUP>16</SUP> For branded pharmaceutical
firms, policies on patenting, licensing, and pricing can cause adverse impacts.<SUP>17</SUP>
According to the former Special Rapporteur, &ldquo;The patent holder of a life-saving medicine has a human rights responsibility to take
all reasonable steps to ensure that the medicine is accessible to all social groups.&rdquo;<SUP>18</SUP>
In our view, a human rights due diligence process would serve as an accountability mechanism allowing Lilly to determine &ldquo;which
health policies and practices are working and which are not, and why, with the objective of improving the realization of the right to
health for all.&rdquo;<SUP>19</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>10</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report (hereinafter, &ldquo;Access to Medicine Report&rdquo;)
can be downloaded at </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://accesstomedicinefoundation.org/resource/2022-access-to-medicine-index</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
pp.7, 12</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>11</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access to Medicine Report, p.5</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>12</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access to Medicine Report, p.13</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>13</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access to Medicine Report, p.14</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>14</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access to Medicine Report, p.70</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>15</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United Nations Human Rights Office of the High Commissioner,
<I>United Nations Guiding Principles on Business and Human Rights</I>, at 16 (2011) (hereinafter, &ldquo;UNGPs&rdquo;) (available at https://www.ohchr.org/documents/publications/GuidingprinciplesBusinesshr_eN.pdf)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>16</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNGPs, at 19.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>17</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">SYMPOSIUM ARTICLE: Human Rights Responsibilities
of Pharmaceutical Companies in Relation to Access to Medicines, 40 J.L. Med. &amp; Ethics 220</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
p.228 (Summer 2012)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>18</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">SYMPOSIUM ARTICLE: Human Rights Responsibilities
of Pharmaceutical Companies in Relation to Access to Medicines, 40 J.L. Med. &amp; Ethics 220</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
p.228 (Summer 2012)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>19</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">SYMPOSIUM ARTICLE: Human Rights Responsibilities
of Pharmaceutical Companies in Relation to Access to Medicines, 40 J.L. Med. &amp; Ethics 220</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
p.226 (Summer 2012)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This communication is not a solicitation of proxy
authority and no proxy cards will be accepted. Vote your proxies in accordance with Eli Lilly&rsquo;s instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Lilly has neither a human rights policy recognizing
the right to health nor a human rights due diligence process. In its Statement in Opposition to the Proposal, Lilly points to its Supplier
Code of Conduct (the &ldquo;Code&rdquo;), but the Code applies only to suppliers, not to Lilly&rsquo;s own business, and is silent on
the right to health. Lilly also touts its commitment to the U.N. Global Compact&rsquo;s Ten Principles. Those principles cover several
important subjects, including labor rights, environmental responsibility, and anti-corruption. They do not, however, mention the right
to health or access to medicines.<SUP>20</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Lilly has come under tremendous scrutiny for
the price of its medicines, especially insulin. Lilly argues that its &ldquo;many actions [taken] over the years to increase insulin access
and affordability around the world&rdquo; make the policy requested in this Proposal unnecessary. We disagree. According to T1 International,
a leading advocacy group for people living with diabetes, manufacturer-sponsored cost sharing programs like &ldquo;$35 insulin caps&rdquo;
can be &ldquo;onerous and challenging for prescribers and pharmacists to use,&rdquo; change frequently, and require patients to allow
their data to be used for direct-to-patient marketing.<SUP>21</SUP>
Lilly markets branded products other than insulin, such as its blockbuster Type 2 diabetes drug Mounjaro; a human rights perspective could
inform Lilly&rsquo;s approach to access to drugs other than insulin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In sum, none of Lilly&rsquo;s existing policies are an adequate substitute
for a human rights policy that includes respect for the human right to health. Viewing business activities through the lens of that human
right would, we believe, ground Lilly&rsquo;s access to medicine initiatives in the human rights principles of equality and non-discrimination,
transparency, participation, and accountability and could foster a more holistic approach to access. Nor do Lilly&rsquo;s policy commitments
incorporate a human rights due diligence process, which would provide a systematic framework for identifying, preventing, mitigating and
remedying adverse human rights impacts Lilly causes or to which Lilly contributes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you have any questions, please contact Laura Krausa at laura.krausa@commonspirit.org.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; padding-top: 2pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: #EEECE1; padding-bottom: 2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>Vote &ldquo;FOR&rdquo; on Shareholder
Proposal #9, &ldquo;[tk]&rdquo; </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>at the Lilly annual general meeting on May 6,
2024. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The filer of this document is Mercy Investment
Services, Inc. 2039 N. Geyer Rd., St. Louis, MO 63131</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>20</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://unglobalcompact.org/what-is-gc/mission/principles</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>21</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.t1international.com/blog/2024/01/11/promised-price-cuts-not-cutting-it-there-no-35-price-cap-insulin/</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This communication is not a solicitation of proxy
authority and no proxy cards will be accepted. Vote your proxies in accordance with Eli Lilly&rsquo;s instructions.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
